Gantzert Investment Company’s Zimmer Biomet ZBH Stock Holding History

Gantzert Investment Company’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.9M	Buy	14,343 +26	+0.2%	+$3.4K	1.71%	25
2020 Q2	$1.66M	Sell	14,317 -165	-1%	-$19K	1.63%	29
2020 Q1	$1.42M	Sell	14,482 -226	-2%	-$29.6K	1.52%	29
2019 Q4	$2.14M	Sell	14,708 -16	-0.1%	-$2.21K	1.95%	25
2019 Q3	$1.96M	Sell	14,724 -190	-1%	-$24.5K	1.92%	26
2019 Q2	$1.71M	Sell	14,914 -47	-0.3%	-$5.5K	1.68%	34
2019 Q1	$1.85M	Sell	14,961 -577	-4%	-$65.6K	1.88%	31
2018 Q4	$1.56M	Buy	+15,538	New	+$1.75M	1.75%	32

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Gantzert Investment Company's ZBH Position: Q3 2020 in Review

Gantzert Investment Company increased its Zimmer Biomet (ZBH) stake by 0.18% in Q3 2020, buying an estimated $3.4K and bringing the position to 14,343 shares worth $1.9M. The position accounts for 1.71% of the portfolio, ranked #25.

Gantzert Investment Company first reported a position in ZBH in Q4 2018 and has held it in 8 quarters since. The position peaked at $2.14M in Q4 2019. 931 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

Gantzert Investment Company held 14,343 shares of Zimmer Biomet worth $1.9M as of Q3 2020.
Gantzert Investment Company bought 26 Zimmer Biomet shares in Q3 2020, an estimated $3.4K.
Zimmer Biomet made up 1.71% of Gantzert Investment Company's portfolio in Q3 2020, its #25 holding.
Gantzert Investment Company first reported a position in Zimmer Biomet in Q4 2018 and has held it in 8 quarters since.
Gantzert Investment Company's Zimmer Biomet position peaked at $2.14M in Q4 2019.
931 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Gantzert Investment Company's 13F filing for Q3 2020, filed 7 Oct 2020.